• ESMO congress 2024

    New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024

  • EORTC-1333-GUCGPEACE III trial

    Late Breaking Results from the EORTC 1333/PEACE III phase III trial

  • Categories:

    EORTC’s presence at ESMO 2024

  • Meet the new EORTC Board
    Categories:

    Meet the new EORTC Board

  • Annual Report 2023
    Categories:

    We are pleased to announce the release of the EORTC 2023 Annual Report

  • ACT EU News Denis Lacombe
    Categories:

    Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group

  • Clinical Trials Day
    Categories:

    Clinical Trials Day 2024: a Q&A on pragmatic clinical trials

  • CMF Workshop panel
    Categories:

    EORTC/EMA workshop suggests an international way forward for treatment optimisation studies